eISSN: 2081-2833
ISSN: 2081-0016
Medycyna Paliatywna/Palliative Medicine
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
2/2015
vol. 7
 
Share:
Share:
more
 
 
abstract:
Case report

The use of oxycodone/naloxone in patients with cancer-associated pain and opioid-induced bowel dysfunction: case reports

Rafał J. Kurzawa
,
Grzegorz Słomian
,
Artur Kłusek

Medycyna Paliatywna 2015; 7(2): 145–148
Online publish date: 2015/08/13
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Moderate to severe chronic pain is one of the main symptoms of cancer. Most of the patients require strong analgesics administration from the third degree of the analgesic ladder as recommended by the World Health Organization (WHO). Bowel dysfunctions, such as constipation are typical side effects during treatment with opioids. In this article one form of causal treatment was presented. It consisted in replacing previously used opioids to oxycodone/naloxone as prolonged release tablets. In addition the problem of co-existing risk factors of constipation and the treatment of pain in patients with cognitive impairment were submitted.
keywords:

pain, opioid-induced constipation, oxycodone/naloxone

Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.